“Thanks to this variety of outcomes, using our magnets offers a range of technological and clinical advantages. These include precision control of implant functions for better therapeutic results, non-invasive adjustments and energy transmission, increased patient comfort due to smaller, more efficient implants and improved safety thanks to strict compliance with legal standards”, reported Mike Shilling, Medical Market Manager at Dexter Magnetic Technologies.
The company is one of the leading developers of magnetic solutions for implantable medical devices, for instance a device to support cardiac function which operates with minimally invasive heart pumps that require miniaturized motors. High magnetic moment ensures the required torque while the high coercive force offers resistance against demagnetization. “This means that we can further reduce the size and width-to-height ratio”, said Mark Schilling. The lymphatic drainage project is currently still in development. It uses magnetic coupling technology to facilitate moving and draining lymphatic fluid and aims to overcome the limitations of the methods used to date.
Ad Statistics
Times Displayed: 6567
Times Visited: 9 Final days to save an extra 10% on Imaging, Ultrasound, and Biomed parts web prices.* Unlimited use now through September 30 with code AANIV10 (*certain restrictions apply)
3D printing’s increasing importance for implant technology
3D printing is gaining importance for implant technology. Formlabs is a leading manufacturer and developer for the entire spectrum of 3D printed hardware, software and materials for prototyping and production. For example, the company develops biocompatible materials for medical applications. During the COMPAMED Innovation Forum, Shiden Yohannes, Manager Medical Market Development at Formlabs, demonstrated how 3D printing makes manufacturing low-cost, patient-specific models for pre-operative planning and training possible. According to Yohannes, a study conducted by Ghent University has shown that 3D printed models can be used for training carotid stenting.
The European MAT(T)ISSE project has the goal of developing an innovative breast bioprosthesis for breast cancer patients. The bioprosthesis (a class 3 medical device) combines a synthetic network with a 3D printed absorbable structure that marks the volume to be reconstructed. This technology allows breast tissue to be regenerated through autologous adipocyte transplantation. The researchers are also studying other applications for reconstructive implants.
Open communication and impermeable sealing at the human-machine interface
